CJC 1295 + Ipamorelin is a natural human growth hormone activating peptide therapy that stimulates your body to produce more of its own HGH
The target sample size was approximately 1,500 women per study, with the goal of enrolling around 550 women for randomization, and collecting over two months of data from at least 450 women during the double-blind treatment phase
Patients entered a run-in treatment period on glimepiride (greater than or equal to 4 mg per day) alone or glimepiride in combination with metformin (greater than or equal to 1500 mg per day)
Clinical outcome: limb sensory symptoms Numbness, tingling (paresthesia)
It is also able to exert protection against retinal pigment epithelial cells (RPEs) by decreasing carbonic anhydrase 1 (CA1) expression (Na et al., 2023)
In every survey over the past 10 years, behavioral health services were the most frequently reported area of benefit expansions